Glomerular expression and elevated serum Bcl-2 and Fas proteins in lupus nephritis: Preliminary findings

Clinical and Experimental Immunology

Volumn 146, Issue 2, 2006, Pages 339-343

  Fathi, N A ^a   Hussein, M R ^b   Hassan, H I ^b   Mosad, E ^a   Galal, H ^a   Afifi, N A ^a  

^a Assiut University Faculty of Medicine   (Egypt)

^b Assiut University   (Egypt)

Author keywords

Bcl 2; Fas; Kidney; Lupus; Nephritis

Indexed keywords

FAS ANTIGEN; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

ADULT; ANTIGENS, CD95; APOPTOSIS; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; MALE; PROTEINURIA; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 33750073183     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03219.x     Document Type: Article

References (20)

1. Takemura T, Murakami K, Miyazato H et al. Expression of Fas antigen and Bcl-2 in human glomerulonephritis. Kidney Int 1995; 48:1886-92.
2. Teh SJ, Dutz JP, Motyka B et al. Fas (CD95)-independent regulation of immune responses by antigen-specific CD4-CD8+ T cells. Int Immunol 1996; 8:675-81.
3. Sano H, Asano K, Minatoguchi S et al. Plasma soluble fas and soluble fas ligand in chronic glomerulonephritis. Nephron 1998; 80:153-61.
4. Fournie G. [Cell death and lupus]. Ann Med Interne (Paris) 1996; 147:472-9.
5. Hussein MR, Haemel AK, Wood GS. Apoptosis and melanoma: molecular mechanisms. J Pathol 2003; 199:275-88.
6. Hussein MR. Apoptosis in the ovary: molecular mechanisms.Hum Reprod Update 2005; 11:162-77.
7. Rose LM, Latchman DS, Isenberg DA. Bcl-2 and Fas, molecules which influence apoptosis.A possible role in systemic lupus erythematosus? Autoimmunity 1994; 17:271-8.
8. Kewalramani R, Singh AK. Immunopathogenesis of lupus and lupus nephritis: recent insights. Curr Opin Nephrol Hypertens 2002; 11:273-7.
9. Hussein MR, Bedaiwy MA, Falcone T. Analysis of apoptotic cell death, Bcl-2, and p53 protein expression in freshly fixed and cryo-preserved ovarian tissue after exposure to warm ischemia. Fertil Steril 2006; 85 Suppl 1:1082-92.
10. Uguz A, Gonlusen G, Ergin M et al. Expression of Fas, Bcl-2 and p53 molecules in glomerulonephritis and their correlations with clinical and laboratory findings. Nephrology (Carlton) 2005; 10:311-6.
11. Uda S, Yoshimura A, Sugenoya Y et al. Mesangial proliferative nephritis in man is associated with increased expression of the cell survival factor, Bcl-2. Am J Nephrol 1998; 18:291-5.
12. Nitta K, Horita S, Honda K et al. Glomerular expression of cell-cycle-regulatory proteins in human crescentic glomerulonephritis. Virchows Arch 1999; 435:422-7.
13. Aringer M, Wintersberger W, Steiner CW et al. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum 1994; 37:1423-30.
14. Baima B, Sticherling M. Apoptosis in different cutaneous manifestations of lupus erythematosus. Br J Dermatol 2001; 144:958-66.
15. Miret C, Font J, Molina R et al. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus. Anticancer Res 2001; 21:3053-9.
16. Kacprzyk F. [Serum level and urinary excretion of soluble Fas (sFas) in patients with primary glomerulopathies]. Pol Arch Med Wewn 2002; 108:843-7.
17. Huang QR, Morris D, Manolios N. Evaluation of the BCL-2 gene locus as a susceptibility locus linked to the clinical expression of systemic lupus erythematosus (SLE). Rheumatol Int 1996; 16:121-4.
18. Sato M, Konuma T, Yanagisawa N et al. Fas-Fas ligand system in the peripheral blood of patients with renal diseases. Nephron 2000; 85:107-13.
19. Yang B, Johnson TS, Thomas GL et al. A shift in the Bax/Bcl-2 balance may activate caspase-3 and modulate apoptosis in experimental glomerulonephritis. Kidney Int 2002; 62:1301-13.
20. Ohsako S, Hara M, Harigai M et al. Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Clin Immunol Immunopathol 1994; 73:109-14.